StockData
Ocean Biomedical, Inc. logo

Ocean Biomedical, Inc. (OCEA) stock

OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)

Close on Oct 19, 2026Market cap $45.51KP/E –Yield –

Ocean Biomedical net income

Net income is the profit left for shareholders after every expense, interest and tax.

Ocean Biomedical's net income for the twelve months ending Mar 31, 2025 was -$30.72M. For fiscal 2024 it was -$9.48M.

Annual net income

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$9.48M–
FY2023Dec 31, 2023-$114.47M–
FY2022Dec 31, 2022-$17.36M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025-$8.24M-163.4%
Q4 FY2024Dec 31, 2024-$1.54M–
Q3 FY2024Sep 30, 2024-$3.70M–
Q2 FY2024Jun 30, 2024-$17.23M–
Q1 FY2024Mar 31, 2024$13.00M–
Q4 FY2023Dec 31, 2023-$16.86M–
Q3 FY2023Sep 30, 2023-$14.09M–
Q2 FY2023Jun 30, 2023-$11.43M–
Q1 FY2023Mar 31, 2023-$72.09M–
Q4 FY2022Dec 31, 2022-$983.00K–
Q3 FY2022Sep 30, 2022-$3.67M–
Q2 FY2022Jun 30, 2022-$7.33M–
Q1 FY2022Mar 31, 2022-$5.38M–
Q3 FY2021Sep 30, 2021-$42.63K–

More Ocean Biomedical figures

See a number that looks wrong?